Molecular Culture® ID for Osteomyelitis Diagnostics
The Challenge of Diagnosing Diabetic Foot Osteomyelitis (DFO)
Diabetic foot osteomyelitis is a severe complication of diabetes, affecting 20% of foot infections and contributing to over 80% of lower extremity amputations. Traditional culture methods are slow and often fail to detect certain bacteria, particularly anaerobic species, limiting effective treatment decisions and posing a significant disease burden.
The Solution: Molecular Culture® ID.
Molecular Culture® ID provides untargeted bacterial species detection within hours, overcoming the limitations of traditional culture methods. This innovative technology enables faster and more comprehensive diagnostics for DFO.
The Impact in Healthcare.
- Results are delivered in hours, not days.
- Detects a broad range of bacterial species, including anaerobes missed by traditional methods.
- Supports targeted therapy, improving treatment outcomes and reducing the risk of amputation.
Clinical Performance of Molecular Culture® ID.
In a multicenter, randomized controlled trial conducted across hospitals in The Netherlands, 53 bone biopsy samples from suspected diabetic foot osteomyelitis cases were analyzed. Molecular Culture® ID demonstrated superior performance compared to traditional culture, identifying a broader range of bacterial species, including hard-to-culture anaerobes, with unmatched speed. This enhanced diagnostic capability enables clinicians to make earlier, more precise treatment decisions, ultimately improving patient outcomes and reducing the risk of complications like amputation.
Request your Starter Kit now.
We are happy to send you a free Molecular Culture® testkit to experience the benefits in practice. Contact us with the form below.
